Skip to main content
. Author manuscript; available in PMC: 2023 Aug 24.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2022 Aug 24;18(7-8):469–481. doi: 10.1080/17425255.2022.2113379

Figure 4. Plasma drug concentration over time under conditions in which the drug concentration exceeds the toxicity threshold.

Figure 4.

Panel A represents a situation in which the patient’s metabolism or transport capabilities are compromised before the start of therapy; in this case, the plasma drug concentration can exceed the threshold for toxicity, resulting in an early onset of injury (violet dashed line). Panel B represents a decrease in the patient’s drug metabolism or exretion during maintenance therapy. In this case, plasma drug concentration rises and has the potential to exceed the toxicity threshold. A new, elevated steady state plasma concentration will ultimately be established (not shown).